PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
线虫增殖与减数分裂的命运决定
基本信息
- 批准号:8258381
- 负责人:
- 金额:$ 28.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAddressAdultAffectAnimalsBindingBinding SitesBiological ModelsCaenorhabditis elegansCell Fate ControlCell NucleusCell divisionCellsChIP-seqCleaved cellDNA BindingDaughterDevelopmentDissectionDistalGenerationsGenesGeneticGenetic TranscriptionGerm CellsGoalsHomeostasisInvertebratesLeadMalignant NeoplasmsMammalsMeiosisMessenger RNAModelingMolecularNotch Signaling PathwayNuclearOncogenicPathway interactionsPatternPopulationProteinsRNA InterferenceReagentReproductionResearchResolutionSignal TransductionStem cellsSystemTemperatureTestingTimeTissuesTranslational ActivationTranslational RepressionTranslationsgain of functiongene discoverygenetic analysisglucagon-like peptide 1in vivoloss of functionmutantnotch proteinpopulation basedrepairedself-renewalstem cell differentiationstem cell niche
项目摘要
DESCRIPTION (provided by applicant): Tissues are formed and maintained by stem cells that produce both daughters that undergo self-renewing proliferation and daughters that differentiate. The mechanisms by which the choice between the self-renewal/ proliferative fate and the differentiated fate are made are not well understood in any system. However, disruption of the decision can cause stem cell loss, resulting tissue depletion, and lead to cancer. Our long-term goal is to understand how the proliferation vs. differentiation decision is made in the C. elegans germline. The C. elegans germline is the major model system for tissues where there are a larger number of stem cells that divide and differentiate through symmetric divisions, in contrast to the more widely studied systems with a small number of stem cells and differentiation through asymmetric division. The GLP-1 Notch signaling pathway induces the germ cell proliferative fate and represses three redundant pathways that promote the meiotic cell fate: the GLD-1 pathway, which acts in translational repression; the GLD-2 pathway, which acts in translational activation; and a third pathway whose existence has been revealed through genetic analysis but no gene products have been identified to date. Notch signaling in mammals is also important in stem cell self-renewal and oncogenic Notch activation can lead to cancer. Project goals address major unanswered questions in the field and include: (1) Determining whether the proliferative zone population is composed of only stem cells or both stem cells and proximal transit amplifying cells. (2) Identifying transcriptional targets of GLP-1 signaling for the proliferative fate and determining regulatory relationships with the three meiotic entry pathways. (3) Identifying the GLD-1 targets that are translationally repressed to promote meiotic entry.
PUBLIC HEALTH RELEVANCE: The proposed research investigates the stem cell versus differentiation decision, which is an essential part of animal development and adult tissue homeostasis. Disruption of the decision can cause stem cell loss, resulting in tissue disfunction, and can lead to cancer.
描述(由申请人提供):组织由干细胞形成和维持,干细胞产生进行自我更新增殖的子细胞和分化的子细胞。在任何系统中,在自我更新/增殖命运和分化命运之间进行选择的机制都没有得到很好的理解。然而,破坏这一决定可能会导致干细胞丢失,导致组织耗尽,并导致癌症。我们的长期目标是了解C.秀丽隐杆线虫生殖系梭秀丽隐杆线虫种系是组织的主要模型系统,其中存在大量通过对称分裂进行分裂和分化的干细胞,而不是更广泛研究的具有少量干细胞和通过不对称分裂进行分化的系统。GLP-1 Notch信号通路诱导生殖细胞增殖命运,并抑制促进减数分裂细胞命运的三条冗余通路:GLD-1通路,其在翻译抑制中起作用; GLD-2通路,其在翻译激活中起作用;以及第三条通路,其存在已通过遗传分析揭示,但迄今尚未鉴定出基因产物。哺乳动物中的Notch信号传导在干细胞自我更新中也是重要的,并且致癌Notch激活可导致癌症。该项目的目标是解决该领域尚未解决的主要问题,包括:(1)确定增殖区人群是否仅由干细胞或干细胞和近端转运扩增细胞组成。(2)确定GLP-1信号传导的转录靶点,以促进增殖命运,并确定与三种减数分裂进入途径的调控关系。(3)鉴定被抑制以促进减数分裂进入的GLD-1靶标。
公共卫生关系:拟议的研究调查了干细胞与分化决定,这是动物发育和成人组织稳态的重要组成部分。破坏这一决定可能导致干细胞损失,导致组织功能障碍,并可能导致癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIM SCHEDL其他文献
TIM SCHEDL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIM SCHEDL', 18)}}的其他基金
Multi-organism platform for functional analysis of Undiagnosed Diseases Network (UDN) variants
用于未确诊疾病网络 (UDN) 变异功能分析的多生物体平台
- 批准号:
10600552 - 财政年份:2022
- 资助金额:
$ 28.88万 - 项目类别:
Multi-organism platform for functional analysis of Undiagnosed Diseases Network (UDN) variants
用于未确诊疾病网络 (UDN) 变异功能分析的多生物体平台
- 批准号:
10213222 - 财政年份:2018
- 资助金额:
$ 28.88万 - 项目类别:
Streamlined capture and curation of unpublished data
简化未发布数据的捕获和管理
- 批准号:
9980493 - 财政年份:2017
- 资助金额:
$ 28.88万 - 项目类别:
IDENTIFICATION OF ERK SUBSTRATES THAT DRIVE PROLIFERATION IN RAS TUMORS
鉴定驱动 RAS 肿瘤增殖的 ERK 底物
- 批准号:
8810230 - 财政年份:2014
- 资助金额:
$ 28.88万 - 项目类别:
IDENTIFICATION OF ERK SUBSTRATES THAT DRIVE PROLIFERATION IN RAS TUMORS
鉴定驱动 RAS 肿瘤增殖的 ERK 底物
- 批准号:
8690290 - 财政年份:2014
- 资助金额:
$ 28.88万 - 项目类别:
PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
线虫增殖与减数分裂的命运决定
- 批准号:
8415952 - 财政年份:2012
- 资助金额:
$ 28.88万 - 项目类别:
Stem cell versus meiotic fate decision in C. elegans
线虫中干细胞与减数分裂的命运决定
- 批准号:
10406345 - 财政年份:2012
- 资助金额:
$ 28.88万 - 项目类别:
PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
线虫增殖与减数分裂的命运决定
- 批准号:
9340215 - 财政年份:2012
- 资助金额:
$ 28.88万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 28.88万 - 项目类别:
Research Grant